Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of ¹⁸F-Fluoromisonidazole and ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography

Table 1

Patient characteristics and the relationship between mRNA expression and clinicopathological characteristics in glioblastoma patients who preoperatively underwent fluorine-18-fluorodeoxyglucose/fluorine-18-fluoromisonidazole PET.

Parameters	No. of patients (%)
Age (years)	Median (±SD)	61.0 (±15.6)
Gender	Female	16
	Male	17
Gene status	IDH wild type	32
	IDH mutant without 1p/19q codeletion	1
Histology	Glioblastoma (grade IV)	33

KPS: Karnofsky performance score; IDH: isocitrate dehydrogenase.